Nonpsychotropic Cannabinoid Acts as a Functional N-methyl-D-aspartate Receptor Blocker

Binding studies using the enantiomers of the synthetic cannabinoid 7-hydroxy-Δ 6-tetrahydrocannabinol 1,1-dimethylheptyl homolog in preparations of rat brain cortical membranes reveal that the (+)-(3S,4S) enantimer HU-211 blocks N-methyl-D-aspartate (NMDA) receptors in a stereospecific manner and th...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 86; no. 23; pp. 9584 - 9587
Main Authors Feigenbaum, Jeffery J., Bergmann, Felix, Richmond, Saul A., Mechoulam, Raphael, Nadler, Varda, Kloog, Yoel, Sokolovsky, Mordechai
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 01.12.1989
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Binding studies using the enantiomers of the synthetic cannabinoid 7-hydroxy-Δ 6-tetrahydrocannabinol 1,1-dimethylheptyl homolog in preparations of rat brain cortical membranes reveal that the (+)-(3S,4S) enantimer HU-211 blocks N-methyl-D-aspartate (NMDA) receptors in a stereospecific manner and that the interaction occurs at binding sites distinct from those of other noncompetitive NMDA antagonists or of glutamate and glycine. Moreover, HU-211 induces stereotypy and locomotor hyperactivity in mice and tachycardia in rat, effects typically caused by NMDA receptor antagonists. HU-211 is also a potent blocker of NMDA-induced tremor, seizures, and lethality in mice. This compound may therefore prove useful as a nonpsychoactive drug that protects against NMDA-receptor-mediated neurotoxicity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.86.23.9584